Literature DB >> 26233632

Pharmacological Management of Pediatric Patients with Comorbid Attention-Deficit Hyperactivity Disorder Oppositional Defiant Disorder.

Daniel F Connor1.   

Abstract

Attention-deficit hyperactivity disorder (ADHD) is a common developmental neurobiological condition of childhood characterized by age-inappropriate degrees of hyperactivity/impulsivity and inattention to tasks requiring sustained vigilance. Oppositional defiant disorder (ODD) is an externalizing behavior disorder characterized by difficulties with emotional and behavioral regulation that frequently brings the child into conflict with authority figures. In the clinical setting, ODD is the most common ADHD comorbidity. The combination portends more severe symptom severity, daily impairment, and a more at-risk prognosis than either disorder alone. We briefly review the literature on the characteristics and treatment of the ADHD and ODD child. A clinical approach to evaluation and treatment of ADHD and ODD is then presented. This approach emphasizes the importance of child and parent psychoeducation about the two disorders alone and in combination, the importance of behavioral management therapy approaches, the possible need for school and academic supports, and the decision to use evidence-based stimulant or non-stimulant ADHD medications depending on symptom severity combined with child and parental wishes and choice.

Entities:  

Mesh:

Year:  2015        PMID: 26233632     DOI: 10.1007/s40272-015-0143-3

Source DB:  PubMed          Journal:  Paediatr Drugs        ISSN: 1174-5878            Impact factor:   3.022


  55 in total

Review 1.  Temperament, personality and developmental psychopathology: a review based on the conceptual dimensions underlying childhood traits.

Authors:  Sarah S W De Pauw; Ivan Mervielde
Journal:  Child Psychiatry Hum Dev       Date:  2010-06

2.  Risperidone added to parent training and stimulant medication: effects on attention-deficit/hyperactivity disorder, oppositional defiant disorder, conduct disorder, and peer aggression.

Authors:  Kenneth D Gadow; L Eugene Arnold; Brooke S G Molina; Robert L Findling; Oscar G Bukstein; Nicole V Brown; Nora K McNamara; E Victoria Rundberg-Rivera; Xiaobai Li; Heidi L Kipp; Jayne Schneider; Cristan A Farmer; Jennifer L Baker; Joyce Sprafkin; Robert R Rice; Srihari S Bangalore; Eric M Butter; Kristin A Buchan-Page; Elizabeth A Hurt; Adrienne B Austin; Sabrina N Grondhuis; Michael G Aman
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  2014-06-12       Impact factor: 8.829

Review 3.  Safety and efficacy of psychosocial interventions used to treat children with attention-deficit/hyperactivity disorder.

Authors:  Steven W Evans; Brandon K Schultz; Joanna M Sadler
Journal:  Pediatr Ann       Date:  2008-01       Impact factor: 1.132

4.  Behavioral, situational, and temporal effects of treatment of ADHD with methylphenidate.

Authors:  R J Schachar; R Tannock; C Cunningham; P V Corkum
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  1997-06       Impact factor: 8.829

Review 5.  Causal heterogeneity in attention-deficit/hyperactivity disorder: do we need neuropsychologically impaired subtypes?

Authors:  Joel T Nigg; Erik G Willcutt; Alysa E Doyle; Edmund J S Sonuga-Barke
Journal:  Biol Psychiatry       Date:  2005-06-01       Impact factor: 13.382

6.  Clinical practice guideline: treatment of the school-aged child with attention-deficit/hyperactivity disorder.

Authors: 
Journal:  Pediatrics       Date:  2001-10       Impact factor: 7.124

7.  A randomized, double-blind, placebo-controlled study of guanfacine extended release in children and adolescents with attention-deficit/hyperactivity disorder.

Authors:  Joseph Biederman; Raun D Melmed; Anil Patel; Keith McBurnett; Jennifer Konow; Andrew Lyne; Noreen Scherer
Journal:  Pediatrics       Date:  2008-01       Impact factor: 7.124

8.  A 30-year prospective follow-up study of hyperactive boys with conduct problems: adult criminality.

Authors:  James H Satterfield; Katherine J Faller; Francis M Crinella; Anne M Schell; James M Swanson; Louis D Homer
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  2007-05       Impact factor: 8.829

9.  Evidence, interpretation, and qualification from multiple reports of long-term outcomes in the Multimodal Treatment study of Children With ADHD (MTA): part I: executive summary.

Authors:  James Swanson; L Eugene Arnold; Helena Kraemer; Lily Hechtman; Brooke Molina; Stephen Hinshaw; Benedetto Vitiello; Peter Jensen; Ken Steinhoff; Marc Lerner; Laurence Greenhill; Howard Abikoff; Karen Wells; Jeffery Epstein; Glen Elliott; Jeffrey Newcorn; Betsy Hoza; Timothy Wigal
Journal:  J Atten Disord       Date:  2008-07       Impact factor: 3.256

Review 10.  School-based interventions for elementary school students with ADHD.

Authors:  George J DuPaul; Matthew J Gormley; Seth D Laracy
Journal:  Child Adolesc Psychiatr Clin N Am       Date:  2014-08-01
View more
  2 in total

1.  Comorbidity prevalence and treatment outcome in children and adolescents with ADHD.

Authors:  Laura Reale; Beatrice Bartoli; Massimo Cartabia; Michele Zanetti; Maria Antonella Costantino; Maria Paola Canevini; Cristiano Termine; Maurizio Bonati
Journal:  Eur Child Adolesc Psychiatry       Date:  2017-05-19       Impact factor: 4.785

2.  An electronic health record (EHR) phenotype algorithm to identify patients with attention deficit hyperactivity disorders (ADHD) and psychiatric comorbidities.

Authors:  Isabella Slaby; Heather S Hain; Debra Abrams; Frank D Mentch; Joseph T Glessner; Patrick M A Sleiman; Hakon Hakonarson
Journal:  J Neurodev Disord       Date:  2022-06-11       Impact factor: 4.074

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.